NS
nancy lynn MD snyderman
Director

nancy lynn MD snyderman insider trades: Alkermes (ALKS) stock buys and sales

Director, Alkermes Last trade Aug 3, 2026 38 Form 4 filings
$2.2M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
4
Open-market trades
since 2019
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where nancy reports to the SEC

Open-market buys and sales

4 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 3, 2026ALKS↓ Sell$2.2M
Mar 4, 2022ALKS↑ Buy$10K
Dec 16, 2020LYRA↑ Buy$10K
Jun 27, 2019AXNX↑ Buy$74K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ALKS insiders

Open-market trades in the last 12 months

About nancy lynn MD snyderman's insider trades

nancy lynn MD snyderman is a director at Alkermes (ALKS). Since Jun 27, 2019, nancy has reported 3 open-market purchases worth $94K and 1 sale worth $2.2M on SEC Form 4. In the last 12 months: 1 sale ($2.2M).

Their filings also include grants and awards (24 filings), option exercises (8 filings), shares withheld for taxes (7 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALKS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.